Richter, Forest Announce Positive IIb Results for Cariprazine for Bipolar Depression

March 31, 2014 7:04 AM

32 0

BUDAPEST--Richter Gedeon Nyrt, (RICHTER.BU) and Forest Laboratories Inc. (FRX) on Monday announced positive phase IIb topline results for Cariprazine for the treatment of Bipolar Depression.

This comes after Richter and Forest announced positive phase IIb topline results for Cariprazine as adjunctive therapy in the treatment of Major Depressive Disorder on March 21.

Read more

To category page

Loading...